Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells

Published:2018-03 Issue: Volume:10 Page:438-449
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Zhang Xingmei,Peng Li,Liang Zhiman,Kou Zhewen,Chen Yue,Shi Guangwei,Li Xiaowen,Liang Yanling,Wang Fang,Shi Yusheng

Funder

National Natural Science Foundation of China

Guangdong Natural Science Foundation

President Foundation of Nanfang Hospital

Program for Changjiang Scholars and Innovative Research Team in University

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference46 articles.

1. Glioblastoma: from molecular pathology to targeted treatment;Cloughesy;Annu. Rev. Pathol.,2014

2. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

3. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma;Choi;Proc. Natl. Acad. Sci. USA,2013

4. Oncogenic EGFR signaling networks in glioma;Huang;Sci. Signal.,2009

5. In vitro selection of RNA molecules that bind specific ligands;Ellington;Nature,1990

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

2. Aptamers as an approach to targeted cancer therapy;Cancer Cell International;2024-03-16

3. Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer;Molecular Therapy - Nucleic Acids;2023-12

4. Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells;Molecular Therapy - Nucleic Acids;2023-09

5. Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?;Cancers;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3